BRCA mutations and gastrointestinal cancers: When to expect the unexpected?
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
BRCA mutations and gastrointestinal cancers: When to expect the unexpected?
Authors
Keywords
-
Journal
World Journal of Clinical Oncology
Volume 12, Issue 7, Pages 565-580
Publisher
Baishideng Publishing Group Inc.
Online
2021-07-21
DOI
10.5306/wjco.v12.i7.565
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Risk of colorectal cancer associated with BRCA1 and/or BRCA2 mutation carriers: systematic review and meta-analysis
- (2020) C. M. Cullinane et al. BRITISH JOURNAL OF SURGERY
- Olaparib for Metastatic Castration-Resistant Prostate Cancer
- (2020) Johann de Bono et al. NEW ENGLAND JOURNAL OF MEDICINE
- Mucinous Histology, BRCA1/2 Mutations, and Elevated Tumor Mutational Burden in Colorectal Cancer
- (2020) Noa Harpaz et al. Journal of Oncology
- The DNA damage response pathway as a land of therapeutic opportunities for colorectal cancer
- (2020) G. Mauri et al. ANNALS OF ONCOLOGY
- Comparison of suspected Lynch syndrome patients carrying BRCA and BRCA‐ like variants with Lynch syndrome probands: Phenotypic characteristics and pedigree analyses
- (2020) Yun Xu et al. Molecular Genetics & Genomic Medicine
- Clinical characteristics and prognostic implications of BRCA-associated tumors in males: a pan-tumor survey
- (2020) Peng Sun et al. BMC CANCER
- Cancer statistics, 2019
- (2019) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Exploiting DNA repair defects in colorectal cancer
- (2019) Nicole M. Reilly et al. Molecular Oncology
- Maintenance Olaparib for Germline BRCA-Mutated Metastatic Pancreatic Cancer
- (2019) Talia Golan et al. NEW ENGLAND JOURNAL OF MEDICINE
- BRCA2 loss‐of‐function germline mutations are associated with esophageal squamous cell carcinoma risk in Chinese
- (2019) Josephine Mun‐Yee Ko et al. INTERNATIONAL JOURNAL OF CANCER
- Precision medicine for metastatic colorectal cancer: an evolving era
- (2019) Irem Guler et al. Expert Review of Gastroenterology & Hepatology
- PARP inhibitor olaparib sensitizes esophageal carcinoma cells to fractionated proton irradiation
- (2019) Shun-ichiro Kageyama et al. JOURNAL OF RADIATION RESEARCH
- BRCA Mutation and Its Association With Colorectal Cancer
- (2018) Aixa E. Soyano et al. Clinical Colorectal Cancer
- Molecular and Pathological Features of Gastric Cancer in Lynch Syndrome and Familial Adenomatous Polyposis
- (2018) Mara Fornasarig et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Malignant Abnormalities in Male BRCA Mutation Carriers
- (2018) Roy Mano et al. JAMA Oncology
- Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2018) Freddie Bray et al. CA-A CANCER JOURNAL FOR CLINICIANS
- OUP accepted manuscript
- (2018) JNCI-Journal of the National Cancer Institute
- Complete pathological response following neoadjuvant FOLFOX chemotherapy in BRCA2-mutant locally advanced rectal cancer: a case report
- (2018) Zhenyu Lin et al. BMC CANCER
- Early-onset colorectal cancer in young individuals
- (2018) Gianluca Mauri et al. Molecular Oncology
- Risks of Breast, Ovarian, and Contralateral Breast Cancer for BRCA1 and BRCA2 Mutation Carriers
- (2017) Karoline B. Kuchenbaecker et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Global trends in esophageal cancer
- (2017) Gautam K. Malhotra et al. JOURNAL OF SURGICAL ONCOLOGY
- Olaparib tablets as maintenance therapy in patients with platinum-sensitive, relapsed ovarian cancer and a BRCA1/2 mutation (SOLO2/ENGOT-Ov21): a double-blind, randomised, placebo-controlled, phase 3 trial
- (2017) Eric Pujade-Lauraine et al. LANCET ONCOLOGY
- Olaparib for Metastatic Breast Cancer in Patients with a Germline BRCA Mutation
- (2017) Mark Robson et al. NEW ENGLAND JOURNAL OF MEDICINE
- Homologous Recombination Deficiency (HRD) Score Predicts Response to Platinum-Containing Neoadjuvant Chemotherapy in Patients with Triple-Negative Breast Cancer
- (2016) M. L. Telli et al. CLINICAL CANCER RESEARCH
- Hereditary cancer syndromes: utilizing DNA repair deficiency as therapeutic target
- (2016) Gaurav Goyal et al. Familial Cancer
- Mutational signatures in esophageal adenocarcinoma define etiologically distinct subgroups with therapeutic relevance
- (2016) Maria Secrier et al. NATURE GENETICS
- Cancer Incidence in First- and Second-Degree Relatives of BRCA1 and BRCA2 Mutation Carriers
- (2016) Haley Streff et al. ONCOLOGIST
- Treatment with the PARP inhibitor, niraparib, sensitizes colorectal cancer cell lines to irinotecan regardless of MSI/MSS status
- (2015) Sybil M Genther Williams et al. Cancer Cell International
- Accuracy of Hereditary Diffuse Gastric Cancer Testing Criteria and Outcomes in Patients With a Germline Mutation in CDH1
- (2015) Rachel S. van der Post et al. GASTROENTEROLOGY
- Germline BRCA Mutations in a Large Clinic-Based Cohort of Patients With Pancreatic Adenocarcinoma
- (2015) Spring Holter et al. JOURNAL OF CLINICAL ONCOLOGY
- Hereditary diffuse gastric cancer: updated clinical guidelines with an emphasis on germlineCDH1mutation carriers
- (2015) Rachel S van der Post et al. JOURNAL OF MEDICAL GENETICS
- Incidence of colorectal cancer in BRCA1 and BRCA2 mutation carriers: results from a follow-up study
- (2013) C M Phelan et al. BRITISH JOURNAL OF CANCER
- Differing effects of adjuvant chemotherapy according to BRCA1 nuclear expression in gastric cancer
- (2013) Jin Won Kim et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Germline and Somatic Mutations in Homologous Recombination Genes Predict Platinum Response and Survival in Ovarian, Fallopian Tube, and Peritoneal Carcinomas
- (2013) Kathryn P. Pennington et al. CLINICAL CANCER RESEARCH
- GermlineBRCAMutations Are Associated With Higher Risk of Nodal Involvement, Distant Metastasis, and Poor Survival Outcomes in Prostate Cancer
- (2013) Elena Castro et al. JOURNAL OF CLINICAL ONCOLOGY
- Prognostic significance of BRCA1 expression in gastric cancer
- (2013) Wenjiao Chen et al. MEDICAL ONCOLOGY
- Loss of BRCA1 expression leads to worse survival in patients with gastric carcinoma
- (2013) Zi-Zhen Zhang WORLD JOURNAL OF GASTROENTEROLOGY
- New Strategies in Barrett's Esophagus: Integrating Clonal Evolutionary Theory with Clinical Management
- (2011) B. J. Reid et al. CLINICAL CANCER RESEARCH
- Risk of cancer other than breast or ovarian in individuals with BRCA1 and BRCA2 mutations
- (2011) A. Moran et al. Familial Cancer
- Gastric cancer in individuals with Li-Fraumeni syndrome
- (2011) Serena Masciari et al. GENETICS IN MEDICINE
- Gastric adenocarcinoma and proximal polyposis of the stomach (GAPPS): a new autosomal dominant syndrome
- (2011) D L Worthley et al. GUT
- High Cancer Risk in Peutz–Jeghers Syndrome: A Systematic Review and Surveillance Recommendations
- (2010) M G F van Lier et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Hereditary diffuse gastric cancer: updated consensus guidelines for clinical management and directions for future research
- (2010) R. C. Fitzgerald et al. JOURNAL OF MEDICAL GENETICS
- Contribution of germ lineBRCA2sequence alterations to risk of familial esophageal cancer in a high-risk area of India
- (2009) M. Kaushal et al. DISEASES OF THE ESOPHAGUS
- Risk and Epidemiological Time Trends of Gastric Cancer in Lynch Syndrome Carriers in The Netherlands
- (2009) Lisette G. Capelle et al. GASTROENTEROLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started